Advertisement

Topics

Diabetes and Kidney Complications Garnering Attention at ISN

09:38 EDT 26 Mar 2019 | Medscape

First results indicating that an SGLT2 inhibitor could improve outcomes for patients with diabetes and chronic kidney disease will be presented at the upcoming nephrology world congress.
Medscape Medical News

Original Article: Diabetes and Kidney Complications Garnering Attention at ISN

NEXT ARTICLE

More From BioPortfolio on "Diabetes and Kidney Complications Garnering Attention at ISN"

Advertisement
Quick Search
Advertisement
Advertisement